Drug Trial Radar · NCT06129864
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,145
Planned (sponsor's estimate)
Start
Dec 14, 2023
Primary completion
Apr 17, 2030
Study completion Feb 28, 2031
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Nov 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess the efficacy and safety of volrustomig compared to observation in participants with unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) who have not progressed after receiving definitive concurrent chemoradiotherapy (cCRT).
Conditions
- Locally Advanced Head and Neck Squamous Cell Carcinoma
Interventions
volrustomigDrug
volrustomig
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) in participants with unresected LA-HNSCC with PD-L1 expressing tumorsTime frame: Up to approximately 8 years
Locations
306 sites in 23 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama · Recruiting
Research Site
Phoenix, Arizona · Recruiting
Research Site
Prescott Valley, Arizona · Active not recruiting
Research Site
Springdale, Arkansas · Withdrawn
Research Site
Fountain Valley, California · Recruiting
Research Site
Fullerton, California · Not yet recruiting
Research Site
Los Angeles, California · Recruiting
Research Site
Orange, California · Withdrawn
Research Site
Santa Rosa, California · Recruiting
Research Site
Whittier, California · Recruiting
Research Site
Aurora, Colorado · Recruiting
Research Site
Colorado Springs, Colorado · Recruiting
Research Site
Lone Tree, Colorado · Recruiting
Research Site
Washington D.C., District of Columbia · Recruiting
Research Site
Fort Myers, Florida · Recruiting
Research Site
Gainesville, Florida · Withdrawn
Research Site
Miami, Florida · Withdrawn
Research Site
Palm Bay, Florida · Recruiting
Research Site
West Palm Beach, Florida · Recruiting
Research Site
Niles, Illinois · Recruiting
Research Site
Des Moines, Iowa · Recruiting
Research Site
Kansas City, Kansas · Completed
Research Site
Louisville, Kentucky · Recruiting
Research Site
Baton Rouge, Louisiana · Recruiting
Research Site
Shreveport, Louisiana · Withdrawn
Research Site
Baltimore, Maryland · Recruiting
Research Site
Bethesda, Maryland · Recruiting
Research Site
Hyattsville, Maryland · Recruiting
Research Site
Towson, Maryland · Recruiting
Research Site
Upper Marlboro, Maryland · Recruiting
Research Site
Boston, Massachusetts · Recruiting
Research Site
Fairhaven, Massachusetts · Recruiting
Research Site
Ann Arbor, Michigan · Recruiting
Research Site
Ann Arbor, Michigan · Withdrawn
Research Site
Minneapolis, Minnesota · Recruiting
Research Site
Columbia, Missouri · Withdrawn
Research Site
St Louis, Missouri · Recruiting
Research Site
St Louis, Missouri · Withdrawn
Research Site
East Brunswick, New Jersey · Withdrawn
Research Site
Hackensack, New Jersey · Recruiting
Showing 40 of 306 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.